Hemostasis management in pediatric mechanical circulatory support.

In a 9-year-old boy, bridging to transplantation was successful with an external biventricular device, the Berlin Heart Excor (Berlin Heart, Berlin, Germany), during a 7-month period. Main long-term complications consisted of infection and hypercoagulability with clotting inside the chambers necessitating six pump exchanges, but without thromboembolic events. This report reviews hemostasis monitoring and management of long-term mechanical circulatory support.

[1]  B. Reichart,et al.  Platelet activation markers in patients with heart assist device. , 2005, Artificial organs.

[2]  Christoph Schmidt,et al.  First clinical experience with the Incor left ventricular assist device. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  D. Loisance,et al.  Platelet activation and aggregation profile in prolonged external ventricular support. , 2004, The Journal of thoracic and cardiovascular surgery.

[4]  Markus J. Wilhelm,et al.  Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator , 2002, Circulation.

[5]  C. Hörmann,et al.  Coagulation monitoring and management of anticoagulation during cardiac assist device support. , 2003, The Annals of thoracic surgery.

[6]  P M Portner,et al.  Improved outcomes with an implantable left ventricular assist system: a multicenter study. , 2001, The Annals of thoracic surgery.

[7]  J. Copeland,et al.  Thoratec Ventricular Assist Devices in Children With Less Than 1.3 m2 of Body Surface Area , 2003, ASAIO journal.

[8]  R. Körfer,et al.  Mechanical ventricular circulatory support in children; Bad Oeynhausen experience. , 2005, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.